FTRE
Price
$14.88
Change
-$0.73 (-4.68%)
Updated
Feb 21 closing price
Capitalization
1.33B
9 days until earnings call
SPRY
Price
$11.24
Change
-$0.54 (-4.58%)
Updated
Feb 21 closing price
Capitalization
1.09B
26 days until earnings call
Ad is loading...

FTRE vs SPRY

Header iconFTRE vs SPRY Comparison
Open Charts FTRE vs SPRYBanner chart's image
Fortrea Holdings
Price$14.88
Change-$0.73 (-4.68%)
Volume$830.53K
Capitalization1.33B
ARS Pharmaceuticals
Price$11.24
Change-$0.54 (-4.58%)
Volume$1.39M
Capitalization1.09B
FTRE vs SPRY Comparison Chart
Loading...
FTRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FTRE vs. SPRY commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FTRE is a Hold and SPRY is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (FTRE: $14.88 vs. SPRY: $11.24)
Brand notoriety: FTRE and SPRY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FTRE: 79% vs. SPRY: 103%
Market capitalization -- FTRE: $1.33B vs. SPRY: $1.09B
FTRE [@Biotechnology] is valued at $1.33B. SPRY’s [@Biotechnology] market capitalization is $1.09B. The market cap for tickers in the [@Biotechnology] industry ranges from $369.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FTRE’s FA Score shows that 1 FA rating(s) are green whileSPRY’s FA Score has 0 green FA rating(s).

  • FTRE’s FA Score: 1 green, 4 red.
  • SPRY’s FA Score: 0 green, 5 red.
According to our system of comparison, FTRE is a better buy in the long-term than SPRY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FTRE’s TA Score shows that 6 TA indicator(s) are bullish while SPRY’s TA Score has 3 bullish TA indicator(s).

  • FTRE’s TA Score: 6 bullish, 2 bearish.
  • SPRY’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, FTRE is a better buy in the short-term than SPRY.

Price Growth

FTRE (@Biotechnology) experienced а -0.60% price change this week, while SPRY (@Biotechnology) price change was -6.49% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.71%. For the same industry, the average monthly price growth was -2.01%, and the average quarterly price growth was +0.86%.

Reported Earning Dates

FTRE is expected to report earnings on Mar 03, 2025.

SPRY is expected to report earnings on May 19, 2025.

Industries' Descriptions

@Biotechnology (-1.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FTRE($1.34B) has a higher market cap than SPRY($1.09B). SPRY YTD gains are higher at: 11.659 vs. FTRE (-16.300). FTRE has higher annual earnings (EBITDA): 7.1M vs. SPRY (-60.51M). SPRY has more cash in the bank: 205M vs. FTRE (105M). SPRY has less debt than FTRE: SPRY (102K) vs FTRE (1.2B). FTRE has higher revenues than SPRY: FTRE (2.98B) vs SPRY (2.57M).
FTRESPRYFTRE / SPRY
Capitalization1.34B1.09B122%
EBITDA7.1M-60.51M-12%
Gain YTD-16.30011.659-140%
P/E RatioN/AN/A-
Revenue2.98B2.57M115,888%
Total Cash105M205M51%
Total Debt1.2B102K1,180,392%
TECHNICAL ANALYSIS
Technical Analysis
FTRESPRY
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
74%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
76%
Momentum
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
84%
MACD
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
70%
Bullish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
75%
Bearish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 3 days ago
71%
Bullish Trend 9 days ago
85%
Declines
ODDS (%)
Bearish Trend 16 days ago
79%
Bearish Trend 12 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 5 days ago
71%
Aroon
ODDS (%)
Bearish Trend 3 days ago
79%
Bullish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
FTRE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AGIRX20.00N/A
N/A
Alger Mid Cap Growth Institutional R
KMKCX82.82N/A
N/A
Kinetics Market Opportunities Adv C
PRESX24.84N/A
N/A
T. Rowe Price European Stock
MVCGX28.23N/A
N/A
MFS Mid Cap Value R1
PGDRX11.44N/A
N/A
Principal Diversified Real Asset R3

FTRE and

Correlation & Price change

A.I.dvisor tells us that FTRE and TECH have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that FTRE and TECH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FTRE
1D Price
Change %
FTRE100%
+1.43%
TECH - FTRE
33%
Poorly correlated
-0.47%
RIGL - FTRE
32%
Poorly correlated
+1.02%
SPRY - FTRE
31%
Poorly correlated
-1.83%
MGTX - FTRE
30%
Poorly correlated
-0.87%
IMNM - FTRE
29%
Poorly correlated
+2.12%
More

SPRY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SPRY has been loosely correlated with LPCN. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if SPRY jumps, then LPCN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPRY
1D Price
Change %
SPRY100%
-1.83%
LPCN - SPRY
63%
Loosely correlated
-0.55%
SLNO - SPRY
38%
Loosely correlated
-0.13%
STRO - SPRY
37%
Loosely correlated
-2.14%
TSVT - SPRY
37%
Loosely correlated
+4.28%
ACLX - SPRY
34%
Loosely correlated
+3.67%
More